Related Experiment Video
Updated: Jul 8, 2026

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
Published on: October 31, 2007
Post-transplant diabetes mellitus in pediatric liver transplantation
Eba Hathout1, Estella Alonso, Ravinder Anand
1Division of Pediatric Endocrinology and Diabetes, Loma Linda University, Loma Linda, CA 92354, USA. ehathout@llu.edu
Insights
Pediatric liver transplant recipients over age 5, hospitalized at transplant, or on early steroids/tacrolimus face higher risks of gastrointestinal issues and post-transplant diabetes mellitus (PTDM). Monitoring is crucial for early detection and management.
Area of Science:
- Pediatric Gastroenterology
- Transplant Hepatology
- Immunology
Background:
- Gastrointestinal (GI) complications and post-transplant diabetes mellitus (PTDM) are significant concerns in pediatric liver transplantation.
- Identifying risk factors is essential for proactive management and improving outcomes in this vulnerable population.
Purpose of the Study:
- To identify recipient and donor characteristics associated with the development of GI and/or PTDM in children undergoing their first liver transplant.
- To analyze factors contributing to early-onset GI/PTDM within 30 days post-transplantation.
Main Methods:
- Analysis of data from 1611 pediatric patients undergoing their first liver transplant, sourced from the SPLIT database.
- Evaluation of recipient factors (age, hospitalization, diagnosis, immunosuppression) and donor factors (type, age, CMV status).
- Multivariate analyses to determine statistically significant associations with GI/PTDM development.
Main Results:
- Gastrointestinal issues and/or PTDM occurred in 13% (214/1611) of pediatric liver transplant recipients.
- Early GI/PTDM (within 30 days) was diagnosed in 78% (166/214) of affected individuals.
- Factors associated with increased early GI/PTDM incidence included: age >5 years at transplant, hospitalization at transplant, primary diagnosis other than biliary atresia, early steroid use, and tacrolimus use.
Conclusions:
- Age, hospitalization status, specific primary diagnoses, and early immunosuppressive strategies (steroids, tacrolimus) are key predictors of early GI/PTDM after pediatric liver transplant.
- Routine monitoring for GI complications and PTDM is recommended for comprehensive short- and long-term care of pediatric liver transplant recipients.
Abstract:
To determine the characteristics of pediatric liver transplant recipients who develop GI and/or PTDM, data on children undergoing their first liver transplant from the SPLIT database were analyzed (n = 1611). Recipient and donor characteristics that were evaluated included age at transplant, gender, race, primary disease, hospitalization status at transplant, BMI, recipient and donor CMV status, donor type, donor age, and primary immunosuppression. GI/PTDM was found in 214 individuals (13%) of whom 166 (78%) were diagnosed within 30 days of transplantation (early GI/PTDM). Multivariate analyses suggests that age >5 yr at transplant, hospitalization at transplant, a primary diagnosis other than BA, early steroid use, and tacrolimus use are associated with increased incidence of early GI. Routine monitoring for the development of GI and post-transplant diabetes is indicated in the short- and long-term care of children after liver transplantation.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Metabolism

